High-dose interferon-α2btreatment prevents chronicity in acute hepatitis C
✍ Scribed by Wolfgang Vogel; Ivo Graziadei; Florian Umlauft; Christian Datz; Franz Hackl; Stefan Allinger; Kurt Grünewald; Josef Patsch
- Book ID
- 105457776
- Publisher
- Springer US
- Year
- 1996
- Tongue
- English
- Weight
- 547 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Chronic hepatitis C is often a progressive liver disease for which there is no satisfactory treatment. We studied the efficacy of recombinant a-interferon or y-interferon in the treatment of this disease in comparison with a control group. Thirty patients were randomly assigned to three groups. Ten
In chronic hepatitis C virus (HCV) infection, the rate of sustained response to interferon is low. We evaluated, in patients responding to a 26-week course of interferon, the effect of high-dose maintenance therapy in preventing relapse. Three hundred and ten patients with chronic HCV infection (38.